Marien Gonzalez-Lorenzo
Overview
Explore the profile of Marien Gonzalez-Lorenzo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
1263
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ridley B, Minozzi S, Gonzalez-Lorenzo M, Del Giovane C, Piggott T, Filippini G, et al.
Cochrane Database Syst Rev
. 2024 Sep;
9:CD015443.
PMID: 39254048
Background: In recent years a broader range of immunomodulatory and immunosuppressive treatment options have emerged for people with progressive forms of multiple sclerosis (PMS). While consensus supports these options as...
2.
Wendebourg M, Poettgen J, Finlayson M, Gonzalez-Lorenzo M, Heesen C, Kopke S, et al.
Eur J Neurol
. 2024 Sep;
31(12):e16452.
PMID: 39225447
Background And Purpose: Fatigue is a common and disabling symptom in multiple sclerosis (MS). Educational interventions have shown potential to reduce fatigue. The aim was to systematically review the current...
3.
Gonzalez-Lorenzo M, Ridley B, Minozzi S, Del Giovane C, Peryer G, Piggott T, et al.
Cochrane Database Syst Rev
. 2024 Jan;
1:CD011381.
PMID: 38174776
Background: Different therapeutic strategies are available for the treatment of people with relapsing-remitting multiple sclerosis (RRMS), including immunomodulators, immunosuppressants and biological agents. Although each one of these therapies reduces relapse...
4.
Tramacere I, Virgili G, Perduca V, Lucenteforte E, Benedetti M, Capobussi M, et al.
Cochrane Database Syst Rev
. 2023 Nov;
11:CD012186.
PMID: 38032059
Background: Multiple sclerosis (MS) is a chronic disease of the central nervous system that affects mainly young adults (two to three times more frequently in women than in men) and...
5.
Giovanardi C, Gonzalez-Lorenzo M, Poini A, Marchi E, Culcasi A, Ursini F, et al.
Integr Med Res
. 2023 Aug;
12(3):100972.
PMID: 37637183
Background: Conventional therapies (CTs), pharmacological (PH) and non-pharmacological (NPH), do not always achieve benefits in the treatment of chronic low back pain (CLBP). We assessed efficacy and safety of acupuncture...
6.
Cinquini M, Rocco N, Catanuto G, Garreffa E, Ferrando P, Gonzalez-Lorenzo M, et al.
Plast Reconstr Surg Glob Open
. 2023 Feb;
11(2):e4821.
PMID: 36845868
Methods: A panel of world-renowned breast specialists was convened to evaluate evidence, express personal viewpoints, and establish recommendation for the use of ADMs for subpectoral one-/two-stage IBBR (compared with no...
7.
Minozzi S, Gonzalez-Lorenzo M, Cinquini M, Berardinelli D, Cagnazzo C, Ciardullo S, et al.
J Clin Epidemiol
. 2022 Sep;
152:47-55.
PMID: 36156301
Objectives: To assess whether the use of the revised Cochrane risk of bias tool for randomized trials (RoB2) in systematic reviews (SRs) adheres to RoB2 guidance. Methods: We searched MEDLINE,...
8.
Puljak L, Parmelli E, Capobussi M, Gonzalez-Lorenzo M, Squizzato A, Moja L, et al.
Front Res Metr Anal
. 2022 May;
7:849019.
PMID: 35494418
Background: Overlapping systematic reviews (SRs) are increasingly frequent in the medical literature. They can easily generate discordant evidence, as estimates of effect sizes and their interpretation might differ from one...
9.
Minozzi S, Lytras T, Gianola S, Gonzalez-Lorenzo M, Castellini G, Galli C, et al.
EClinicalMedicine
. 2022 Apr;
46:101331.
PMID: 35360146
Background: Influenza is one of the most common respiratory viral infections worldwide. Numerous vaccines are used to prevent influenza. Their selection should be informed by the best available evidence. We...
10.
Moja L, Banzi R, Cabitza F, Capobussi M, Castellini G, Cereda D, et al.
Recenti Prog Med
. 2022 Jan;
113(1):30-35.
PMID: 35044373
This article is about current challenges to evidence-based medicine (EMB) in Italy. The authors, who share a 20-year commitment to the field of clinical research, discuss what they define as...